Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nippon Venture Capital is an independent Japanese venture capital firm founded in 1996, recognized as one of the largest and most active VCs in Japan. It primarily invests in early-stage startups in sectors including life science, biotechnology, therapeutics, healthcare, medical devices, IT, communications, and environmental technology. Its portfolio includes over 1,000 startups, with more than 160 IPOs as of 2024
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nippon Venture Capital.